SOURCE: CDEX Inc.

May 05, 2008 09:00 ET

General Robert H. "Doc" Foglesong, U.S. Air Force (Retired), Appointed to the Board of Directors of CDEX Inc.

TUCSON, AZ--(Marketwire - May 5, 2008) - CDEX Inc. (OTCBB: CEXI) announces the appointment of General Robert H. Foglesong, U.S. Air Force (Retired), to its Board of Directors, effective May 1, 2008. General Foglesong (ret) is currently the President and Executive Director of the Appalachian Leadership and Education Foundation, a non-profit foundation operating to identify the next generation of leaders in Appalachia and to support their journey toward academic, leadership, and character excellence. Previously, he served as the 18th President of Mississippi State University and has had a long and distinguished career in the U.S. Air Force serving in various positions including Commander, U.S. Air Forces in Europe and Vice Chief of Staff of the Air Force. General Foglesong (ret) is a graduate of West Virginia University (BS, MS and PhD - Chemical Engineering) and serves on the Board of Directors of Massey Energy and Michael Baker Corporation. (For a more complete bio, see www.cdex-inc.com.)

"I'm honored and delighted to be part of the CDEX Team," said General Foglesong (ret). "The character of the organization and the work ethic of the CDEX employees speak volumes about the upward potential and the quality of the products CDEX provides -- nationally and internationally. I'm excited to be in this formation!!"

"Doc Foglesong is a man of integrity and moral conviction, with a world view shared by the CDEX Team," said Malcolm Philips, CDEX CEO and Chairman of the Board. "Leading organizations and bringing assets together to solve problems in national and international settings has been Doc Foglesong's life work. That is also the CDEX vision as we assist in addressing major world problems such as medication errors, illegal drug use, explosive detection and distribution channels contaminated by counterfeit products. Doc Foglesong will be a major addition to the CDEX Team as we continue to move products into the mainstream national and international markets that assist with solving these problems. We are both pleased and honored that he has joined us in this work."

About CDEX Inc.

CDEX, a technology company currently developing products using its patented/patent pending chemical detection technologies, is focused on (i) identification of substances of concern (e.g., explosives and illegal drugs, for security markets); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of compounded medication and detection of counterfeit or sub-par products, for the medical and brand protection markets). ValiMed™ and the Meth Scanner™ are CDEX solutions for the healthcare and security markets. Corporate headquarters and R&D facilities are located in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com or contact Malcolm Philips (mphilips@cdex-inc.com) 520.745.5172 X 210.

Any Non-Historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other similar words. These statements pose risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the Protection of intellectual property and proprietary information, and other risks detailed from time-to-time in filings with the Sec. There is no obligation to publicly update any forward-looking statements.

Contact Information